
|Articles|April 1, 2017
- Applied Clinical Trials-04-01-2017
- Volume 26
- Issue 4
Applied Clinical Trials, April/May 2017 Issue (PDF)
Click the title above to open the Applied Clinical Trials April/May 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 9 years ago
Orphan Drug Surge Raises Regulatory and Development Challengesover 9 years ago
EFGCP Puts Renewed Emphasis on Complex Studiesover 9 years ago
What’s New in the 'New’ EU Personalized Medicines Bid?over 9 years ago
The Elusive Goal of Optimizing Development Operationsover 9 years ago
IDMP: An International Standard for Lifecycle Data Managementover 9 years ago
Ethics Under the Clinical Trials Regulationover 9 years ago
Choose Consistency Over Chaosover 9 years ago
Regulatory Considerations for 21st Century Paperless Trialsover 9 years ago
Malaysia’s Clinical Research EcosystemAdvertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Validity, Reliability, and Regulatory Considerations for Consumer Devices in Clinical Research Data Collection
2
ACT Brief: Real-Time Review Ecosystem Approach, AI Infrastructure Before Tools, and FDA Peptide Compounding Access
3
ACT Brief: ESG as Commercial Selection Factor, Real-Time Monitoring Scale Readiness, and FDA Cancer Trial Eligibility Expansion
4
FDA Finalizes Three Guidances to Broaden Cancer Clinical Trial Eligibility
5




